| Literature DB >> 35136187 |
Valentina Capone1, Nicola Persico2, Alfredo Berrettini3, Stèphane Decramer4,5,6,7, Erika Adalgisa De Marco3, Diego De Palma8, Alessandra Familiari9, Wout Feitz10, Maria Herthelius11, Vytis Kazlauskas12, Max Liebau13, Gianantonio Manzoni3, Michal Maternik14, Giovanni Mosiello15, Joost Peter Schanstra4,5, Johan Vande Walle16, Elke Wühl17, Elisa Ylinen18, Aleksandra Zurowska19, Franz Schaefer20, Giovanni Montini21,22.
Abstract
Fetal lower urinary tract obstruction (LUTO) is associated with high mortality and postnatal morbidity caused by lung hypoplasia and impaired kidney function. Specific diagnostic features that can guide clinical approach and decisions are lacking; thus, the European Reference Network for Rare Kidney Diseases established a work group to develop recommendations regarding the clinical definition, diagnosis and management of prenatally detected LUTO. The work group recommends the use of antero-posterior diameter of renal pelvis as the most reliable parameter for suspecting obstructive uropathies and for suspecting prenatal LUTO in the presence of fetal megacystis. Regarding prenatal and postnatal prognosis of fetuses with LUTO, the risk of fetal and neonatal death depends on the presence of oligohydramnios or anhydramnios before 20 weeks' gestation, whereas the risk of kidney replacement therapy cannot be reliably foreseen before birth. Parents of fetuses with LUTO must be referred to a tertiary obstetric centre with multidisciplinary expertise in prenatal and postnatal management of obstructive uropathies, and vesico-amniotic shunt placement should be offered in selected instances, as it increases perinatal survival of fetuses with LUTO.Entities:
Mesh:
Year: 2022 PMID: 35136187 DOI: 10.1038/s41585-022-00563-8
Source DB: PubMed Journal: Nat Rev Urol ISSN: 1759-4812 Impact factor: 16.430